Table 2.
Meta-regression analysis of the heterogeneity of the basic characteristics.
| Covariatesa | ESb | Coefficient | 95% CI | P value |
|---|---|---|---|---|
| Male | 24 | − 0.418 | − 1.152 to 0.316 | 0.264 |
| Median age | 27 | 0.014 | − 0.004 to 0.032 | 0.116 |
| Median KPS | 14 | − 0.002 | − 0.014 to 0.011 | 0.811 |
| EGOG ≤ 1 | 13 | − 0.092 | − 0.421 to 0.604 | 0.726 |
| Multiple sites | 17 | 0.085 | − 0.369 to 0.539 | 0.715 |
| DLBCL | 18 | 0.046 | − 0.562 to 0.655 | 0.882 |
| CSF cytology | 20 | 0.236 | − 0.214 to 0.685 | 0.305 |
| CSF protein | 10 | 0.014 | − 0.599 to 0.628 | 0.964 |
| Ocular | 22 | 0.171 | − 0.403 to 0.745 | 0.560 |
| Single dose of MTX (mg/m2) | 29 | − 0.013 | − 0.041 to 0.014 | 0.350 |
| The number of Cycles | 29 | 0.051 | 0.007 to 0.095 | 0.025 |
| CR best | 28 | 0.003 | − 0.000 to 0.006 | 0.096 |
ES effect size, CI confidence interval.
aAll of the data in this analysis are presented in Table 1.
bNumber of studies used in the regression model.